- Home
- UUU vs BRTX Comparison
UUU vs BRTX Comparison
Compare UUU & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- BRTX
- Stock Information
- Founded
- UUU 1969
- BRTX 1997
- Country
- UUU United States
- BRTX United States
- Employees
- UUU N/A
- BRTX N/A
- Industry
- UUU Electronic Components
- BRTX Managed Health Care
- Sector
- UUU Technology
- BRTX Health Care
- Exchange
- UUU Nasdaq
- BRTX Nasdaq
- Market Cap
- UUU 12.6M
- BRTX 12.8M
- IPO Year
- UUU N/A
- BRTX N/A
- Fundamental
- Price
- UUU $4.90
- BRTX $1.54
- Analyst Decision
- UUU
- BRTX
- Analyst Count
- UUU 0
- BRTX 0
- Target Price
- UUU N/A
- BRTX N/A
- AVG Volume (30 Days)
- UUU 130.2K
- BRTX 331.3K
- Earning Date
- UUU 11-18-2025
- BRTX 11-13-2025
- Dividend Yield
- UUU 20.41%
- BRTX N/A
- EPS Growth
- UUU N/A
- BRTX N/A
- EPS
- UUU 1.19
- BRTX N/A
- Revenue
- UUU $22,789,285.00
- BRTX $605,200.00
- Revenue This Year
- UUU N/A
- BRTX $232.67
- Revenue Next Year
- UUU N/A
- BRTX $52.92
- P/E Ratio
- UUU $4.12
- BRTX N/A
- Revenue Growth
- UUU 30.84
- BRTX 247.62
- 52 Week Low
- UUU $1.65
- BRTX $1.19
- 52 Week High
- UUU $8.27
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- UUU 47.96
- BRTX 47.02
- Support Level
- UUU $4.64
- BRTX $1.49
- Resistance Level
- UUU $5.79
- BRTX $1.70
- Average True Range (ATR)
- UUU 0.63
- BRTX 0.09
- MACD
- UUU -0.05
- BRTX -0.01
- Stochastic Oscillator
- UUU 12.32
- BRTX 33.33
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.